| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $306.5M | -13.7% |
| Cost of Revenue | $181.0M | -11.6% |
| Gross Profit | $125.5M | -16.5% |
| R&D Expense | $20.0M | -2.2% |
| SG&A Expense | $107.5M | +0.6% |
| Operating Income | $16.9M | -59.8% |
| Pre-tax Income | $17.6M | -54.3% |
| Income Tax | $7.7M | -37.8% |
| Net Income | $9.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $51.2M | -9.3% |
| Inventory | $84.2M | -4.5% |
| Current Assets | $236.9M | -2.5% |
| Total Assets | $450.9M | -4.4% |
| Current Liabilities | $53.0M | -13.9% |
| Long-term Debt | $31.4M | -1.3% |
| Total Liabilities | $129.1M | -8.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $19.8M | -56.8% |
| Investing Cash Flow | -$12.9M | +14.6% |
| Financing Cash Flow | -$9.4M | +73.8% |
| -61.4% |
| EPS (Basic) | $0.74 | -60.8% |
| EPS (Diluted) | $0.74 | -60.6% |
| Stockholders' Equity |
| $322.0M |
| -2.4% |